FID
发表于 2025-3-30 10:50:40
http://reply.papertrans.cn/29/2849/284832/284832_51.png
蔓藤图饰
发表于 2025-3-30 14:57:37
http://reply.papertrans.cn/29/2849/284832/284832_52.png
LIMIT
发表于 2025-3-30 20:08:52
http://reply.papertrans.cn/29/2849/284832/284832_53.png
不合
发表于 2025-3-31 00:17:55
http://reply.papertrans.cn/29/2849/284832/284832_54.png
直觉没有
发表于 2025-3-31 03:58:53
Computational Cardiac Safety Testingtainty, how to assess simulation reliability and reproducibility, and therefore how to establish trust in model predictions. We examine applications of simulations to date, particularly in the context of the comprehensive in vitro proarrhythmia Assay (CiPA). The chapter concludes with a discussion of future avenues for research.
夹克怕包裹
发表于 2025-3-31 05:20:07
http://reply.papertrans.cn/29/2849/284832/284832_56.png
packet
发表于 2025-3-31 11:46:02
http://reply.papertrans.cn/29/2849/284832/284832_57.png
反省
发表于 2025-3-31 16:30:30
Springer Nature Switzerland AG 2024
Blanch
发表于 2025-3-31 21:31:22
The adverse effects of new chemical entities (NCE) in animals and humans can manifest as changes in the structural, biochemical, or physiological status of the organism (see Fig. .). In the preclinical safety assessment process, toxicological procedures have traditionally focused on the structural and biochemical consequences of drug actions.
nettle
发表于 2025-4-1 01:39:44
Safety Pharmacology: IntroductionThe adverse effects of new chemical entities (NCE) in animals and humans can manifest as changes in the structural, biochemical, or physiological status of the organism (see Fig. .). In the preclinical safety assessment process, toxicological procedures have traditionally focused on the structural and biochemical consequences of drug actions.